Jeffrey Gould Moore
Amministratore Delegato presso Curileum Discovery Ltd
Profilo
Jeffrey Gould Moore is the founder of Phylogix, Inc. which was founded in 1998.
He was the President & Chief Executive Officer from 1998 to 2009.
Currently, he is the Chief Executive Officer & Director at Curileum Discovery Ltd since 2013.
Dr. Moore's former jobs include being an Executive Director & MD-Novel Therapies at Genedrive Plc from 2010 to 2013 and a Principal at ImClone LLC.
Dr. Moore's education includes a doctorate from George Washington University and an undergraduate degree from The Colorado College.
Posizioni attive di Jeffrey Gould Moore
| Società | Posizione | Inizio |
|---|---|---|
Curileum Discovery Ltd
 Curileum Discovery Ltd Miscellaneous Commercial ServicesCommercial Services Curileum Discovery Ltd engages in research and development of novel therapeutic targets & drugs. The company was founded by Jeffrey Gould Moore on October 03, 2013 and is headquartered in Harrow, the United Kingdom. | Amministratore Delegato | 03/10/2013 |
Precedenti posizioni note di Jeffrey Gould Moore
| Società | Posizione | Fine |
|---|---|---|
| GENEDRIVE PLC | Direttore/Membro del Consiglio | 10/10/2013 |
Phylogix, Inc.
 Phylogix, Inc. Pharmaceuticals: MajorHealth Technology Phylogix, Inc. develops therapeutic drugs. It conducts research on tissue protection and oncology. The firm develops drug candidates in preclinical development, called FRIL to protect cancer patients from the toxic side-effects of chemotherapy. The company was founded in 1998 and is headquartered in Waltham, MA | Fondatore | 02/09/2009 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Formazione di Jeffrey Gould Moore
| George Washington University | Doctorate Degree |
| The Colorado College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENEDRIVE PLC | Health Technology |
| Aziende private | 3 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Phylogix, Inc.
Phylogix, Inc. Pharmaceuticals: MajorHealth Technology Phylogix, Inc. develops therapeutic drugs. It conducts research on tissue protection and oncology. The firm develops drug candidates in preclinical development, called FRIL to protect cancer patients from the toxic side-effects of chemotherapy. The company was founded in 1998 and is headquartered in Waltham, MA | Health Technology |
Curileum Discovery Ltd
Curileum Discovery Ltd Miscellaneous Commercial ServicesCommercial Services Curileum Discovery Ltd engages in research and development of novel therapeutic targets & drugs. The company was founded by Jeffrey Gould Moore on October 03, 2013 and is headquartered in Harrow, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Jeffrey Gould Moore